Clinical Trials Arena January 12, 2026
A new co-innovation lab in the San Francisco Bay area will see Lilly and NVIDIA scientists work alongside each other to fuel drug discovery improvements.
Eli Lilly and NVIDIA will establish a new artificial intelligence (AI) co-innovation lab, as the companies look to use each other’s expertise to advance drug development.
The lab, which will be based in the San Francisco Bay area, will see the US drugmaker and tech giant jointly invest up to $1bn over five years to level-up drug discovery. The partnership was announced at the 2026 J.P. Morgan Healthcare Conference, held from 12 to 15 January in San Francisco.
The aim is for the building to provide a base in which Lilly’s biology and scientific experts...
Today's Sponsors
Today's Sponsor